higher production efficiency, reduced production cost, quality systems improvement, environmental care as well as increasing variety of goods and packaging; 2) investments in research and development; 3
Glass Ayutthaya (SGA2), which expect to start commissioning in mid-2019. Personal Care gross margin improvement will be driven by premiumization and mix transition. 2019 overall profitability target are
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company
Highlights - FY19 Net profit* was at THB 3,259 million (+8.4% YoY), with net profit* margin of 12.7% (+30 bps YoY), where the improvement mainly came from growth in revenues of core businesses and favorable
sales were at THB 6,328 million, where the growth was accelerated to +7.2% YoY. In domestic markets, beverages and personal care continued their growth momentum at 9.4% and 5.8% respectively, while
, the tourism sector and a recovery in exports due to an improvement in the economies of our trading partners. As a result there has been an increase in the purchasing power of consumers in major cities
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the second quarter of 2019 at the end of 30th June 2019 as follows
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 30th September 2018 as
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as